Ask HopeStage to review this study with me
Leave your email and HopeStage can help you better understand this study.
Study reference: NCT07207239. HopeStage can help you review the study, but cannot decide medical eligibility.
Enrolling By InvitationNCT07207239
Effect of Theta-burst rTMS Therapy on the Clinical and Cognitive Symptoms of people with Therapy Resistant Depression and Response Prediction With Neuroimaging Methods.
This study is enrolling by invitation in Hungary. It focuses on depression.
DepressionDeviceOver 18 Years
Key information made simple
This study is looking at whether repetative Transcranial Magnetic Stimulation (rTMS), theta-burst protocol can help people with Transcranial Magnetic Stimulation, Repetitive or Depression - depression. Participants take part in repetative Transcranial Magnetic Stimulation (rTMS), theta-burst protocol and complete follow-up assessments. Taking part may give some people access to repetative Transcranial Magnetic Stimulation (rTMS), theta-burst protocol, but direct benefit is not guaranteed.
Your next step
The official record suggests in-person participation through a clinic, with sites including Department of Psychiatry and Psychotherapy in Budapest. Participation appears to involve assessments along with scans or samples to help researchers understand patterns more clearly. The main fit is usually matching the main diagnosis and meeting the main study requirements, while common reasons not to take part include active substance or alcohol problems that could affect the results and major medical issues that could make participation unsuitable. The official record does not list a formal phase, which usually means this is focused more on feasibility, delivery, or support than a standard drug-development stage.
Questions to ask before joining
- What are the exact eligibility criteria, and what could exclude someone?
- How many visits, assessments, or follow-ups are expected, and over what period?
- What risks, side effects, practical burdens, or alternatives should be understood first?
- Who should be contacted to confirm locations, timing, compensation, and next steps?
Things to check before joining
- Sponsor
- Semmelweis University
- Sponsor type
- University
- Main activity
- medication or study treatment
- Intervention
- Not available
- Time commitment
- multiple visits or assessments
- Study phase
- Not available
- Enrollment
- Not available
- Recruitment status
- Enrolling By Invitation
- Source
- Official registry link
Key study information
- Official title
- Effect of Theta-burst rTMS Therapy on the Clinical and Cognitive Symptoms of Patients With Therapy Resistant Depression and Response Prediction With Neuroimaging Methods.
- Condition
- Transcranial Magnetic Stimulation, Repetitive; Depression - Major Depressive Disorder
- Study status
- Enrolling By Invitation
- Sponsor / lead affiliation
- Semmelweis University
- Location / country
- Hungary
- Registry
- ClinicalTrials.gov
- External trial ID
- NCT07207239
Why this study may matter
This study may matter because it adds public evidence around depression. HopeStage presents it as a starting point for understanding the study, checking the official source, and preparing questions with a care team.
For you
Taking part may give access to a new approach being evaluated.
It requires regular visits and structured follow-up.
Requires travel, with in-person participation in Hungary.
Registry reference
This page links back to the public source record so people can verify details directly with the registry and research team.
If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.
- Official title
- Effect of Theta-burst rTMS Therapy on the Clinical and Cognitive Symptoms of Patients With Therapy Resistant Depression and Response Prediction With Neuroimaging Methods.
- Source
- ClinicalTrials.gov
- Official registry link
- Open official registry
- External trial ID
- NCT07207239
Not medical advice
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
Questions about this study
What is Effect of Theta-burst rTMS Therapy on the Clinical and Cognitive Symptoms of people with Therapy Resistant Depression and Response Prediction With Neuroimaging Methods.?
This study is exploring medication or study treatment for people with depression. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed.
Who is behind this study, and what type of sponsor is it?
This study is sponsored by Semmelweis University. Based on the sponsor name or official registry information, it appears to be a university. You should verify the details in the official registry record.
What does participation involve, what phase is it, and what should I ask about safety?
This study may involve medication or study treatment, study visits, and assessments. The time commitment is multiple visits or assessments. The study phase is not available in HopeStage data. Check the official source record to see whether a phase is listed. Enrollment is not available in HopeStage data. HopeStage cannot say whether a study is safe or right for you. Before joining, ask the research team about possible risks, time commitment, visits, side effects, compensation, safety monitoring, and whether participation may affect your current care.
Where can I verify the study details?
Use the official source record linked on this page to check the full study description, recruitment status, eligibility criteria, locations, sponsor information, phase, enrollment, contact details, and any listed risks or requirements.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me